Peregrine Asset Advisers’s Merck MRK Stock Holding History

Peregrine Asset Advisers’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9M	Buy	70,065 +55,787	+391%	+$6.53M	1.95%	10
2026 Q1	$1.72M	Sell	14,278 -37	-0.3%	-$4.27K	0.46%	58
2025 Q4	$1.51M	Hold	14,315	–	–	0.43%	56
2025 Q3	$1.2M	Sell	14,315 -850	-6%	-$70K	0.36%	66
2025 Q2	$1.2M	Sell	15,165 -360	-2%	-$28.6K	0.37%	67
2025 Q1	$1.39M	Sell	15,525 -450	-3%	-$42K	0.52%	55
2024 Q4	$1.59M	Buy	15,975 +390	+3%	+$40.2K	0.59%	48
2024 Q3	$1.77M	Buy	15,585 +1,350	+9%	+$160K	0.61%	50
2024 Q2	$1.76M	Hold	14,235	–	–	0.69%	43
2024 Q1	$1.88M	Sell	14,235 -7,264	-34%	-$895K	0.75%	38
2023 Q4	$2.34M	Buy	21,499 +7,014	+48%	+$728K	1.14%	26
2023 Q3	$1.49M	Buy	+14,485	New	+$1.56M	0.77%	33
2022 Q3	–	Sell	-37,756	Closed	-$3.44M	–	77
2022 Q2	$3.44M	Buy	+37,756	New	+$3.35M	2.51%	17
2022 Q1	–	Sell	-27,286	Closed	-$2.09M	–	135
2021 Q4	$2.09M	Buy	+27,286	New	+$2.17M	0.85%	44
2020 Q4	–	Sell	-54,118	Closed	-$4.28M	–	136
2020 Q3	$4.28M	Buy	+54,118	New	+$4.24M	2.35%	15
2020 Q2	–	Sell	-1,803	Closed	-$132K	–	132
2020 Q1	$132K	Buy	+1,803	New	+$142K	0.1%	104
2019 Q2	–	Sell	-35,982	Closed	-$2.86M	–	124
2019 Q1	$2.86M	Buy	+35,982	New	+$2.69M	1.65%	19

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Peregrine Asset Advisers's MRK Position: Q2 2026 in Review

Peregrine Asset Advisers increased its Merck (MRK) stake by 391% in Q2 2026, buying an estimated $6.53M and bringing the position to 70,065 shares worth $9M. The position accounts for 1.95% of the portfolio, ranked #10.

Peregrine Asset Advisers first reported a position in MRK in Q1 2019 and has held it in 17 quarters since. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

Peregrine Asset Advisers held 70,065 shares of Merck worth $9M as of Q2 2026.
Peregrine Asset Advisers bought 55,787 Merck shares in Q2 2026, an estimated $6.53M.
Merck made up 1.95% of Peregrine Asset Advisers's portfolio in Q2 2026, its #10 holding.
Peregrine Asset Advisers first reported a position in Merck in Q1 2019 and has held it in 17 quarters since.
3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Peregrine Asset Advisers's 13F filing for Q2 2026, filed 10 Aug 2026.